The Latest Cardiac and Vascular News
Additional real-world outcomes further demonstrate safety, efficacy and procedural reproducibility of the FARAPULSE™ Pulsed Field Ablation System* Results from global trial of the POLARx™ Cryoablation System* meet safety and effectiveness endpoints MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company’s key electrophysiology […]
On May 19, 2023 at the annual Hearth Rhythm Society congress in New Orleans, Louisiana USA, Philips presented an abstract highlighting recent research demonstrating how AI may be used to help predict life-threatening ventricular arrhythmias. The study, entitled Near-Term Prediction of Life-Threatening Ventricular Arrhythmias using Artificial Intelligence-Enabled Single Lead Ambulatory ECG, […]
The CARDIO4Cities Accelerator by Novartis Foundation and IntraHealth International aims to replicate the successful CARDIO4Cities approach in 30 major cities within three years to transform cardiovascular population health and equity globally. Results of initial programs in São Paulo, Dakar and Ulaanbaatar show the cost-effective approach averted up to 13% of strokes and 12% […]
Ground-breaking research is the first to link real-world health outcomes to the quality of remote monitoring and data management. Results show significant disparities in mortality rates depending on the method of remote monitoring used. CAMBRIDGE, Mass., May 22, 2023 /PRNewswire/ — Implicity, a leader in remote patient monitoring and cardiac data management solutions, […]
– Self-administration of etripamil in patients experiencing AFib-RVR episodes resulted in a substantial reduction in ventricular rate which was sustained over 60 minutes – Data featured in an oral session at the Heart Rhythm 2023 Annual Meeting – Company to host virtual KOL conference call and webcast to discuss etripamil […]
The study met secondary study endpoints and long-term sensor use was associated with significant improvements in patient quality-of-life metrics and low event rates for heart failure hospitalization and death LISLE, Ill., May 22, 2023 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), […]
“Gold Standard” SphygmoCor® Technology to be Used to Identify Care Outcomes Associated with Routine Monitoring of Patients with Elevated Blood Pressure IRVINE, Calif., May 22, 2023 /PRNewswire/ — ATCOR Medical, a subsidiary of CardieX and developer of innovative medical devices and digital health solutions to optimize hypertension management and improve clinical trial patient outcomes, today announced […]
Data Presented at Late-Breaking Session at Heart Rhythm Society 2023: Paves Way for Premarket Approval Application for Federal Drug Administration Approval and Commercialisation The pivotal SOLVE-CRT study evaluated EBR Systems’ WiSE® CRT System, the world’s first and only wireless, inside the left ventricle of the heart, pacing system for heart […]
A team of six leading European interventional radiologists used the LIBERTY® Surgical Robotic System and performed a total of 48 catheterizations HINGHAM, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Surgical Robotic System, the first single-use endovascular robotic system, today announced a […]
IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the PEERLESS II trial, Inari’s third randomized controlled trial (RCT) in […]
